Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment

NCT00121992 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1060

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Docetaxel
DRUG: 5-fluorouracil
DRUG: Doxorubicin
DRUG: Cyclophosphamide

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]